LinkedInFacebookTwitterRssEmail
(832) 968-8698|sales@avancebio.com

News & Events

11 03, 2026

Avance Biosciences to Exhibit at the World Vaccine Congress 2026

2026-03-11T15:38:36+00:00

Avance Biosciences will be exhibiting at the World Vaccine Congress in Washington, DC, where we will highlight our analytical testing services that support vaccine development programs. Our team provides potency assay development, next-generation sequencing, and cell-based assays designed to help advance RNA therapeutics and mRNA vaccine candidates from research through regulatory submission.[...]

Avance Biosciences to Exhibit at the World Vaccine Congress 20262026-03-11T15:38:36+00:00
20 01, 2026

Avance Biosciences to Exhibit at Festival of Biologics USA 2026

2026-01-20T19:38:44+00:00

Avance Biosciences will be exhibiting at Festival of Biologics USA 2026 in San Diego. Visit us at Booth #322 to learn how our CGMP-, GLP-, and CLIA-compliant bioanalytical services support biologics development, from assay development and validation to potency, immunogenicity, and advanced analytical testing[...]

Avance Biosciences to Exhibit at Festival of Biologics USA 20262026-01-20T19:38:44+00:00
13 01, 2026

FDA Increases Flexibility on CMC Requirements for Cell and Gene Therapies to Advance Innovation

2026-01-13T17:32:22+00:00

The FDA is clarifying its flexible approach to chemistry, manufacturing, and control (CMC) requirements for cell and gene therapies, helping sponsors accelerate development and prepare for Biologics License Applications while maintaining rigorous standards for safety, quality, purity, and potency.

FDA Increases Flexibility on CMC Requirements for Cell and Gene Therapies to Advance Innovation2026-01-13T17:32:22+00:00
6 01, 2026

How Consistent Assay Performance Reduces Batch Failures

2026-01-06T19:41:07+00:00

Inconsistent assay performance is a common but often overlooked cause of batch failures. Robust, reproducible analytical and bioanalytical assays help reduce risk, improve decision-making, and support reliable batch release across drug development and manufacturing...

How Consistent Assay Performance Reduces Batch Failures2026-01-06T19:41:07+00:00
30 12, 2025

What PERT Signals About the Future of Gene Editing Manufacturing and Regulation

2025-12-30T15:07:31+00:00

A new prime editing strategy, PERT, enables disease-agnostic treatment of nonsense mutations by permanently converting an endogenous tRNA into a suppressor tRNA, with major implications for scalable gene-editing manufacturing and regulation...

What PERT Signals About the Future of Gene Editing Manufacturing and Regulation2025-12-30T15:07:31+00:00
23 12, 2025

What “Fit-for-Purpose” Really Means in Bioanalytical Method Development

2025-12-24T16:24:58+00:00

Fit-for-purpose bioanalytical methods align assay performance with development stage and risk, ensuring data are reliable, efficient, and defensible while supporting critical scientific, regulatory, and CMC decisions across modern drug development programs...

What “Fit-for-Purpose” Really Means in Bioanalytical Method Development2025-12-24T16:24:58+00:00
16 12, 2025

New FDA Final Guidance on Development of Therapeutic Protein Biosimilars: Analytical Considerations for Biologics Developers

2025-12-23T18:12:35+00:00

The FDA’s new guidance on therapeutic protein biosimilars emphasizes rigorous analytical assessment as the foundation for demonstrating similarity. Developers must focus on physicochemical, functional, and quality attributes to streamline regulatory approval and reduce clinical study requirements.

New FDA Final Guidance on Development of Therapeutic Protein Biosimilars: Analytical Considerations for Biologics Developers2025-12-23T18:12:35+00:00
9 12, 2025

Why We Brought PacBio HiFi Online at Avance: The Accuracy Needed for Plasmid QC

2025-12-23T22:11:57+00:00

Avance Biosciences now offers PacBio HiFi long-read sequencing, providing highly accurate, full-length plasmid analysis. This technology ensures precise detection of variants, contaminants, and structural anomalies for reliable plasmid QC...

Why We Brought PacBio HiFi Online at Avance: The Accuracy Needed for Plasmid QC2025-12-23T22:11:57+00:00
3 12, 2025

Avance Biosciences Launches Potency & Cell-Based Assay Center in Houston

2025-12-24T14:51:32+00:00

HOUSTON, December 3, 2025 /PRNewswire/ — Avance Biosciences today announced the opening of its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company's capabilities in potency and functional cell-based assays under GMP compliance [...]

Avance Biosciences Launches Potency & Cell-Based Assay Center in Houston2025-12-24T14:51:32+00:00
2 12, 2025

Why Cell Therapy Developers Are Moving From Sanger to NGS for Identity & Purity Testing

2025-12-23T18:16:45+00:00

Next-generation sequencing (NGS) outperforms Sanger for cell therapy testing, offering higher sensitivity, full-length vector analysis, and population-level variant detection to ensure genomic integrity, regulatory compliance, and scalable quality control...

Why Cell Therapy Developers Are Moving From Sanger to NGS for Identity & Purity Testing2025-12-23T18:16:45+00:00
Go to Top